Literature DB >> 6332843

Expression of Lyb-5 and Mls determinants by Peyer's patch B lymphocytes of X-linked immunodeficient mice.

J H Eldridge, L J Yaffe, J J Ryan, H Kiyono, I Scher, J R McGhee.   

Abstract

Treatment of the Peyer's patch (PP) B cells from X-linked immunodeficient (xid) (CBA/N X DBA/2)F1 male mice with anti-Lyb-5 plus complement kills approximately 75% of these cells, although xid spleen B cells are unaffected. Cytotoxic depletion of Lyb-5+ cells renders the xid PP B cell population unable to generate an in vitro direct plaque-forming cell response to the TI-2 antigen TNP-Ficoll. In addition, the B cell-enriched population from the PP of xid (CBA/N X CBA/J)F1 male mice were strong stimulators of proliferation in an M1s-defined MLR, thereby demonstrating that they also express the M1s antigen(s). Two cell surface antigens associated with mature B cells are therefore expressed by xid PP B cells, suggesting that the TNP-Ficoll responsive cells in this population are mature B cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332843

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway.

Authors:  Ruyue Xu; Xinkuang Liu; Amin Li; Li Song; Jiaojiao Liang; Jiafeng Gao; Xiaolong Tang
Journal:  J Mol Med (Berl)       Date:  2022-02-05       Impact factor: 4.599

2.  Stimulation of gut-associated lymphoid cells by IL-4 and B-cell growth factor II.

Authors:  S L Tonkonogy; S L Swain
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

3.  Defective immunoglobulin M responses to vaccination or infection with Schistosoma mansoni in xid mice.

Authors:  R Correa-Oliveira; A Sher
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

Review 4.  Targeting neoantigens for cancer immunotherapy.

Authors:  Xuan Zhao; Xiaoxin Pan; Yi Wang; Yi Zhang
Journal:  Biomark Res       Date:  2021-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.